Voyageur Pharmaceuticals (CVE:VM) Trading Up 21.4% – Should You Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shot up 21.4% on Wednesday . The stock traded as high as C$0.09 and last traded at C$0.09. 1,238,946 shares were traded during trading, an increase of 1,152% from the average session volume of 98,928 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Up 11.1 %

The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$13.95 million, a price-to-earnings ratio of -10.00 and a beta of 0.32. The company has a 50-day moving average of C$0.07 and a 200-day moving average of C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.